Latest announcement News
FDA approves durvalumab for muscle invasive bladder cancer
The Food and Drug Administration approved durvalumab (Imfinzi,…
HHS, FDA to Phase Out Petroleum-Based Synthetic Dyes in Nation’s Food Supply
The U.S. Department of Health and Human Services…
Lupin Receives US FDA EIR for Drug-Device Combination products at Nagpur Injectable Facility
🔸 Global pharmaceutical major Lupin Limited announced today…
Novartis to invest $23bn into US-based infrastructure over next five years
The commitment will expand the company’s current manufacturing,…
FDA Commissioner Makary Announces New Policy on Individuals Serving on FDA Advisory Committees
In keeping with U.S. Department of Health and…
Lupin Foundation Organizes State-Level Workshop to Enhance Healthcare Systems in Rajasthan
Lupin Human Welfare & Research Foundation (Lupin Foundation),…
Lupin Announces the Acquisition of Renascience in the United Kingdom
Lupin healthcare (UK) Acquires Renascience Pharma to Expand…
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
Glenmark Launches Vancomycin Hydrochloride for Injection in the…
